XML 82 R55.htm IDEA: XBRL DOCUMENT
v3.23.1

Share-based compensation (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2022
Disclosure of terms and conditions of share-based payment arrangement [line items] |
Disclosure of number and weighted average exercise prices of share options [Table Text Block] |
|  | 2022 |  |  | 2021 |
|  |  |  |  | Weighted |  |  |  |  |  | Weighted |
|  | Number of |  |  | average |  |  | Number of |  |  | average |
|  | options |  |  | exercise price |  |  | options |  |  | exercise price |
|  |  |  |  | $ |  |  |  |  |  | $ |
Balance - Beginning of period |  | 3,730,580 |  |  | 14.09 |  |  | 4,240,869 |  |  | 14.22 |
Granted (i) |  | 684,100 |  |  | 14.25 |  |  | 763,700 |  |  | 13.27 |
Exercised |  | (309,749 | ) |  | 13.56 |  |  | (1,043,903 | ) |  | 13.75 |
Forfeited / Cancelled |  | (35,135 | ) |  | 13.48 |  |  | (58,866 | ) |  | 13.45 |
Expired |  | (557,874 | ) |  | 18.02 |  |  | (171,220 | ) |  | 16.04 |
Balance - End of period |  | 3,511,922 |  |  | 13.55 |  |  | 3,730,580 |  |  | 14.09 |
Options exercisable - End of period |  | 1,916,888 |  |  | 13.40 |  |  | 1,881,416 |  |  | 14.78 |
(i) Options were granted to officers, management, employees and/or consultants.
Disclosure of range of exercise prices of outstanding share options [Table Text Block] |
|  |  | Options outstanding |  | Options exercisable |
|  |  |  | Weighted |  |  |  |
|  |  |  | average |  |  |  |
|  |  | Weighted | remaining |  |  | Weighted |
Exercise |  |  | average | contractual |  |  | average |
price range |  | Number | exercise price | life (years) |  | Number | exercise price |
$ |  |  | $ |  |  |  | $ |
10.58 - 12.97 |  | 1,209,007 | 12.72 | 2.6 |  | 714,175 | 12.73 |
13.10 - 14.78 |  | 2,136,101 | 13.77 | 2.8 |  | 1,106,165 | 13.56 |
15.97 - 17.12 |  | 166,814 | 16.67 | 2.5 |  | 96,548 | 16.57 |
|  | 3,511,922 | 13.55 | 2.8 |  | 1,916,888 | 13.40 |
Disclosure of detailed information about options, valuation assumptions [Table Text Block] |
|  |  | 2022 |  |  | 2021 |
| Dividend per share |  | 1.5% |  |  | 1.5% |
| Expected volatility |  | 41% |  |  | 40% |
| Risk-free interest rate |  | 2.6% |  |  | 0.7% |
| Expected life |  | 47 months |  |  | 46 months |
| Weighted average share price |  | $14.25 |  |  | $13.27 |
| Weighted average fair value of options granted |  | $4.38 |  |  | $3.66 |
Disclosure of deferred and restricted share units [Table Text Block] |
|  | 2022 |  | 2021 |
|  | DSU (i) |  |  | RSU (ii) |  |  | DSU (i) |  |  | RSU (ii) |
Balance - Beginning of period |  | 376,203 |  |  | 878,397 |  |  | 408,564 |  |  | 1,242,902 |
Granted |  | 78,200 |  |  | 275,520 |  |  | 64,720 |  |  | 293,610 |
Reinvested dividends |  | 6,018 |  |  | 13,483 |  |  | 5,185 |  |  | 15,102 |
Settled |  | (30,846 | ) |  | (278,806 | ) |  | (102,266 | ) |  | (398,173 | )
Forfeited (iii) |  | - |  |  | (35,791 | ) |  | - |  |  | (275,044 | )
Balance - End of period |  | 429,575 |  |  | 852,803 |  |  | 376,203 |  |  | 878,397 |
Balance - Vested |  | 350,822 |  |  | - |  |  | 311,010 |  |  | - |
(i) Unless otherwise decided by the Board of Directors of the Company, the DSU vest the day prior to the next annual general meeting and are payable in common shares, cash or a combination of common shares and cash, at the sole discretion of the Company, to each non-executive director when he or she leaves the board or is not re-elected. The value of the payout is determined by multiplying the number of DSU expected to be settled at the payout date by the closing price of the Company's shares on the day prior to the grant date. The fair value is recognized over the vesting period. On the settlement date, one common share will be issued for each DSU, after deducting any income taxes payable on the benefit earned by the director that must be remitted by the Company to the tax authorities. The DSU granted in 2022 have a weighted average value of $14.71 per DSU ($15.54 per DSU in 2021). (ii) On December 31, 2019, 150,000 RSU were granted to an officer (with a value of $12.70 per RSU), which vested and were payable in equal tranches over a three-year period (1/3 per year), in common shares, cash or a combination of common shares and cash, at the sole discretion of the Company. An additional number of 75,000 RSU were also granted (with a value of $12.70 per RSU) and vested in 2021 following the acquisition by the officer of a total of 75,000 common shares of the Company. The remaining RSU vest and are payable in common shares, cash or a combination of common shares and cash, at the sole discretion of the Company, three years after the grant date, one half of which depends on the achievement of certain performance measures. The value of the payout is determined by multiplying the number of RSU expected to be vested at the payout date by the closing price of the Company's shares on the day prior to the grant date. The fair value is recognized over the vesting period and is adjusted in function of the applicable terms for the performance-based components, when applicable. On the settlement date, one common share is issued for each RSU, after deducting any income taxes payable on the benefit earned by the employee that must be remitted by Osisko to the tax authorities. The RSU granted in 2022 have a weighted average value of $14.26 per RSU ($13.24 per RSU in 2021). (iii) In 2021, 215,812 RSU held by employees and officers of the Company, who were transferred to Osisko Development as of January 1, 2021 were forfeited and new RSU were granted by Osisko Development in an equivalent value to these employees and officers. At the time of the transfer, Osisko Development was a subsidiary of the Company (Note 31).

X
- Definition The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2022-03-24 -Paragraph 45 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45_b&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of the range of exercise prices for outstanding share options. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2022-03-24 -Paragraph 45 -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45_d&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of deferred and restricted share units explanatory + References No definition available. + Details
Name: | or_DisclosureOfDeferredAndRestrictedShareUnitsExplanatory
Namespace Prefix: | or_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of detailed information about options, valuation assumptions [Table Text Block] + References No definition available. + Details
Name: | or_DisclosureOfDetailedInformationAboutOptionsValuationAssumptionsExplanatory
Namespace Prefix: | or_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration